Cardiovascular Diseases

Water Drinking Effective for Orthostatic Hypotension

An UK study found that bolus water drinking is superior to other nonpharmacological interventions for older people with orthostatic hypotension (OH). A total of 150 orthostatic challenges were performed in 25 older people (age 60–92 years). The response rate (of participants whose systolic blood pressure [SBP] drop improved by ≥10 mm Hg) to bolus water drinking was 56%, with standing SBP increasing by 12 mm Hg. Physical counter maneuvers were efficacious in 44% but had little effect on standing SBP (+7.5 mm Hg). Abdominal compression was efficacious in 52% and improved standing SBP (+10 mm Hg). Compression stockings were the least efficacious therapy (32%) and had little effect on standing SBP (+6 mm Hg). However, no intervention improved symptoms during standing. There were no adverse events. The findings suggests that bolus water drinking should be the standard first-line nonpharmacological intervention for older people with OH. Source: http://n.neurology.org/

hyangiu

Recent Posts

Early-Life Sugar Restriction Linked to Lower Risk of Early-Onset Cancer

Early-life sugar restriction during pregnancy and infancy was associated with a 34% lower risk of…

2 days ago

Domain-Specific Physical Activity and Dementia Risk

Higher levels of physical activity were associated with lower risks of all-cause dementia, Alzheimer’s disease,…

5 days ago

BMI and Waist Circumference Jointly Predict Mortality Risk in Older Adults

In US adults aged ≥65 years, overweight and class I–II obesity were associated with lower…

5 days ago

Longitudinal Heart Stress Status Predicts CVD and Mortality in Older Adults

In community-dwelling older adults without prior cardiovascular disease (CVD), new or persistent heart stress (HS)—defined…

6 days ago

The Obesity Paradox in Colorectal Cancer May Reflect Prediagnostic Weight Loss

In the German multicenter study of 5,521 patients with colorectal cancer (CRC), the apparent survival…

1 week ago

Stopping Statins for Primary Prevention After Age 75? Evidence from a Randomized Trial

In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD)…

2 weeks ago

This website uses cookies.